BeStock  
Stocks › Biotechnology › RARE

Ultragenyx Pharmaceutical RARE

US equityMarket cap rank #2801Biotechnology
$16.48 −$0.74 (-4.30%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $16.50 +0.12%
Open$16.94
Prev close$17.22
Day range$16.43 – $17.35
Volume3.01M
Market cap$1.68B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership117.6%+7.01 pts vs. prior quarter
Institutions holding364-24 vs. prior quarter
Insider trades (recent)30 buys / 20 sellsNet buying
Short interest23.96% of floatDays to cover 8.3 · as of 30 Oct 2026
Short-sale volume share13.2%5-day average of daily volume

Short-sale volume as % of daily volume

3%14%24%35%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$200.9K (7 inflow days, 13 outflow days).

Net flow by order size, last 20 sessions

+$1.2MSuper−$967.4KBig−$5.9MMid+$6.4MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 41.1% of shares outstanding.

Largest holders

  • BlackRock11.25%
  • Vanguard Portfolio Management, LLC8.28%
  • RTW Investments, LP7.67%
  • State Street Global Advisors7.42%
  • AQR Capital Management6.43%
  • Madison Avenue Partners, LP6.21%
  • Vanguard Capital Management, LLC4.23%
  • Two Sigma Investments, LP3.56%

By investor type

  • Mutual Fund67.43%
  • Hedge Fund36.94%
  • Public Company5.44%
  • VC/PE Fund4.01%
  • Individual/Insider3.49%
  • Private Company2.40%
  • Insurance Company0.51%
  • Government Pension Fund0.36%

Reported short interest has risen from 16.12% to 23.96% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Madison Avenue Partners, LP Hedge Fund 2026/Q3 +6,307,798 6.2%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,628,970 8.3%
State Street Global Advisors Mutual Fund 2026/Q3 +1,379,312 7.4%
GW&K Investment Management, LLC Mutual Fund 2026/Q3 +826,666 2.3%
BlackRock Mutual Fund 2026/Q3 +778,577 11.3%
Scout Investments, Inc. Mutual Fund 2026/Q3 +743,419 0.7%
Raymond James Financial, Inc. Public Company 2026/Q3 +742,295 0.8%
Jane Street Group, LLC Private Company 2026/Q3 +695,674 0.7%
Citigroup Inc. Public Company 2026/Q3 +467,239 0.8%
Barclays PLC Public Company 2026/Q3 +455,599 0.6%
RTW Investments, LP Hedge Fund 2026/Q3 +4,148,100 7.7%
BlackRock Mutual Fund 2026/Q3 +3,354,678 10.8%
AQR Capital Management Hedge Fund 2026/Q3 +1,972,711 6.4%
Jacobs Levy Equity Management Inc Mutual Fund 2026/Q3 +1,508,648 2.9%
MPM BioImpact LLC VC/PE Fund 2026/Q3 +1,418,215 1.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
14 Oct 2026 Howard Horn Executive VP of Corporate Strategy & CFO Open Market Disposition -7,066 $15.27 13,026
14 Sep 2026 Theodore Huizenga Senior VP, Corporate Controller & Principal Accounting Officer Open Market Disposition -1,283 $13.57 30,856
2 Sep 2026 Theodore Huizenga Senior VP, Corporate Controller & Principal Accounting Officer Open Market Disposition -161 $13.99 31,963
2 Aug 2026 Howard Horn Executive VP of Corporate Strategy & CFO Open Market Disposition -4,696 $24.92 96,295
2 Aug 2026 Karah Parschauer Chief Legal Officer & Executive VP of Corporate Affairs Open Market Disposition -1,900 $24.92 38,397
30 Jun 2026 Howard Horn Executive VP of Corporate Strategy & CFO Open Market Disposition -4,698 $33.13 4,695
14 Jun 2026 Corazon Sanders Independent Director Open Market Disposition -2,000 $25.05 13,344
14 Jun 2026 Karah Parschauer Chief Legal Officer & Executive VP of Corporate Affairs Open Market Disposition -1,899 $24.62 40,297
31 May 2026 Howard Horn Executive VP of Corporate Strategy & CFO Open Market Disposition -4,653 $23.77 9,392
17 May 2026 Shehnaaz Suliman Independent Director Open Market Disposition -5,740 $25.12 20,200
13 May 2026 Daniel Welch Independent Non-Executive Chairperson Other Acquisition +7,751 – 7,751
13 May 2026 Daniel Welch Independent Non-Executive Chairperson Other Derivative Acquisition +14,058 $25.80 14,058
13 May 2026 Matthew Fust Independent Director Other Acquisition +7,751 – 7,751
13 May 2026 Matthew Fust Independent Director Other Derivative Acquisition +14,058 $25.80 14,058
13 May 2026 Shehnaaz Suliman Independent Director Other Acquisition +7,751 – 7,751
13 May 2026 Shehnaaz Suliman Independent Director Other Derivative Acquisition +14,058 $25.80 14,058
13 May 2026 Deborah Dunsire Independent Director Other Acquisition +7,751 – 7,751
13 May 2026 Deborah Dunsire Independent Director Other Derivative Acquisition +14,058 $25.80 14,058
13 May 2026 Corazon Sanders Independent Director Other Acquisition +7,751 – 7,751
13 May 2026 Corazon Sanders Independent Director Other Derivative Acquisition +14,058 $25.80 14,058

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 23,624,682 24.0% 8.3
15 Oct 2026 20,145,283 20.4% 5.2
30 Sep 2026 20,349,877 20.6% 3.1
15 Sep 2026 16,571,956 16.8% 2.2
31 Aug 2026 17,144,354 17.4% 8.0
14 Aug 2026 15,887,767 16.1% 7.8

Discussion

No comments yet — be the first to weigh in on RARE.

Sign in to join the discussion.

Scroll to Top